Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

LKB1-dependent signaling pathways.

Dario R Alessi1, Kei Sakamoto, Jose R Bayascas

  • 1Medical Research Council, Protein Phosphorylation Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, Scotland. d.r.alessi@dundee.ac.uk

Annual Review of Biochemistry
|June 8, 2006
PubMed
Summary

The LKB1 protein kinase, mutated in Peutz-Jeghers cancer syndrome, acts as a tumor suppressor by regulating cell energy, polarity, and proliferation. Its activity is controlled by STRAD and MO25 interactions, impacting cellular pathways.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>LRRK2</i> in Focus: A Global Browser Linking Genetic Diversity to Functional Effects.

medRxiv : the preprint server for health sciences·2026
Same author

Large-scale functional annotation establishes a reference framework for human <i>LRRK2</i> variants.

medRxiv : the preprint server for health sciences·2026
Same author

Addressing the Challenges of Translating LRRK2 Biology into Disease-Modifying Therapies: The LRRK2 Investigative Therapeutics Exchange Initiative.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Elucidating the molecular interplay between LRRK2 and Rab GTPases.

bioRxiv : the preprint server for biology·2026
Same author

Ex Vivo LRRK2 Activation in Asian G2385R and R1628P Variant Carriers and Idiopathic Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Variants in the proteasome regulator PSMF1 cause a phenotypic spectrum from parkinsonism to perinatal lethality.

Nature communications·2026

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Peutz-Jeghers syndrome is a hereditary cancer predisposition syndrome linked to mutations in the LKB1 gene.
  • LKB1 (Liver kinase B1) is a serine/threonine kinase crucial for cellular energy homeostasis and tumor suppression.
  • Understanding LKB1's tumor suppressor mechanisms is vital for developing new cancer therapies.

Purpose of the Study:

  • To review recent findings on the tumor suppressor functions of the LKB1 protein kinase.
  • To elucidate the regulatory mechanisms controlling LKB1's cellular localization and activity.
  • To explore LKB1's role in cell polarity and energy sensing.

Main Methods:

  • Review of genetic and biochemical studies on LKB1.
  • Analysis of LKB1 interactions with STRAD and MO25.

Related Experiment Videos

  • Examination of LKB1's downstream signaling pathways.

    • Main Results:

    • LKB1's tumor suppressor activity involves regulating cell proliferation, polarity, and energy metabolism.
    • LKB1 localization and activity are modulated by its interaction with STRAD and MO25.
    • LKB1 phosphorylates and activates 14 AMP-activated protein kinase (AMPK)-related kinases.

    Conclusions:

    • LKB1 is a critical tumor suppressor with multifaceted roles beyond proliferation control.
    • The LKB1-STRAD-MO25 complex represents a key regulatory hub in cellular signaling.
    • Studying Peutz-Jeghers syndrome has revealed novel pathways relevant to multiple diseases.